SCHEMBL25974262

SCHEMBL25974262

CC(C)(C)OC(=O)N1CCC(CNC(=O)c2cc3nc(-c4ccccc4)cc(-c4ccccc4)n3n2)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.56
ALDH1A1 P00352 7/20 0.56
HPGD P15428 5/20 0.56
HTT P42858 4/20 0.56
LMNA P02545 4/20 0.56
NPSR1 Q6W5P4 3/20 0.56
TDP1 Q9NUW8 1/20 0.56
PKM P14618 1/20 0.52
ACKR3 P25106 1/20 0.51
MAPT P10636 5/20 0.51
MAPK1 P28482 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.49
TP53 P04637 4/20 0.48
ACACB O00763 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ADRA2A P08913 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25969028 0.85 KDM4E (0.60) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL25974180 0.84 KDM4E (0.54) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL25969143 0.82 KDM4E (0.62) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL25969035 0.82 KDM4E (0.58) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL25974158 0.82 KDM4E (0.66) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL25969153 0.81 KDM4E (0.60) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL25974199 0.78 KDM4E (0.60) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL25974223 0.77 TP53 (0.53) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL14720440 0.77 KDM4E (0.76) KDM4EALDH1A1LMNAPKMACKR3
SCHEMBL25970339 0.76 KDM4E (0.60) KDM4EALDH1A1HPGDHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250161307-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2025-05-22 US disclosed
WO-2023141866-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250161307-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE SMOX, SRM, SMS KDM4E 1480/4885ALDH1A1 160/4885HPGD 701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.